These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9590013

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Hyperprolinemia type II].
    Endo F.
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):155-7. PubMed ID: 9590014
    [No Abstract] [Full Text] [Related]

  • 4. The severe form of type I hyperprolinaemia results from homozygous inactivation of the PRODH gene.
    Jacquet H, Berthelot J, Bonnemains C, Simard G, Saugier-Veber P, Raux G, Campion D, Bonneau D, Frebourg T.
    J Med Genet; 2003 Jan; 40(1):e7. PubMed ID: 12525555
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.
    Clelland JD, Read LL, Drouet V, Kaon A, Kelly A, Duff KE, Nadrich RH, Rajparia A, Clelland CL.
    Schizophr Res; 2014 Jun; 156(1):15-22. PubMed ID: 24787057
    [Abstract] [Full Text] [Related]

  • 8. [Hyperprolinemia].
    Matsumura R.
    Ryoikibetsu Shokogun Shirizu; 2000 Jun; (29 Pt 4):389. PubMed ID: 11031977
    [No Abstract] [Full Text] [Related]

  • 9. Long-term neuropsychiatric follow-up in hyperprolinemia type I.
    Di Rosa G, Nicotera AG, Lenzo P, Spanò M, Tortorella G.
    Psychiatr Genet; 2014 Aug; 24(4):172-5. PubMed ID: 24842239
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Type I hyperprolinemia: genotype/phenotype correlations.
    Guilmatre A, Legallic S, Steel G, Willis A, Di Rosa G, Goldenberg A, Drouin-Garraud V, Guet A, Mignot C, Des Portes V, Valayannopoulos V, Van Maldergem L, Hoffman JD, Izzi C, Espil-Taris C, Orcesi S, Bonafé L, Le Galloudec E, Maurey H, Ioos C, Afenjar A, Blanchet P, Echenne B, Roubertie A, Frebourg T, Valle D, Campion D.
    Hum Mutat; 2010 Aug; 31(8):961-5. PubMed ID: 20524212
    [Abstract] [Full Text] [Related]

  • 13. Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome.
    Clelland CL, Read LL, Baraldi AN, Bart CP, Pappas CA, Panek LJ, Nadrich RH, Clelland JD.
    Schizophr Res; 2011 Sep; 131(1-3):139-45. PubMed ID: 21645996
    [Abstract] [Full Text] [Related]

  • 14. [Hyperprolinemia and hydroxyprolinemia].
    Berger R, Broyer M.
    Presse Med (1893); 1969 May 28; 77(26):957-8. PubMed ID: 5795142
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Type I hyperprolinemia.
    Shivananda, Christopher R, Kumar P.
    Indian J Pediatr; 2000 Jul 28; 67(7):541-3. PubMed ID: 10957843
    [Abstract] [Full Text] [Related]

  • 17. [Type I Hyperprolinemia - What about the Kidney?].
    Rizzo M, Amicone M, Sellitti ML, Marino A, Sannino A, Capuano I, Pisani A.
    G Ital Nefrol; 2023 Dec 22; 40(6):. PubMed ID: 38156540
    [Abstract] [Full Text] [Related]

  • 18. Hyperprolinemia is a risk factor for schizoaffective disorder.
    Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, Lerond J, Allio G, Haouzir S, Tillaux A, Bellegou C, Fouldrin G, Delamillieure P, Ménard JF, Dollfus S, D'Amato T, Petit M, Thibaut F, Frébourg T, Campion D.
    Mol Psychiatry; 2005 May 22; 10(5):479-85. PubMed ID: 15494707
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.